1. Home
  2. ALG vs NNNN Comparison

ALG vs NNNN Comparison

Compare ALG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALG
  • NNNN
  • Stock Information
  • Founded
  • ALG 1955
  • NNNN 2021
  • Country
  • ALG United States
  • NNNN Germany
  • Employees
  • ALG N/A
  • NNNN N/A
  • Industry
  • ALG Industrial Machinery/Components
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ALG Industrials
  • NNNN Health Care
  • Exchange
  • ALG Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • ALG 2.4B
  • NNNN 2.2B
  • IPO Year
  • ALG 1993
  • NNNN 2025
  • Fundamental
  • Price
  • ALG $187.41
  • NNNN $23.38
  • Analyst Decision
  • ALG Buy
  • NNNN
  • Analyst Count
  • ALG 2
  • NNNN 0
  • Target Price
  • ALG $242.50
  • NNNN N/A
  • AVG Volume (30 Days)
  • ALG 71.0K
  • NNNN 75.2K
  • Earning Date
  • ALG 10-30-2025
  • NNNN 11-04-2025
  • Dividend Yield
  • ALG 0.64%
  • NNNN N/A
  • EPS Growth
  • ALG N/A
  • NNNN N/A
  • EPS
  • ALG 9.82
  • NNNN 0.06
  • Revenue
  • ALG $1,596,647,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • ALG $1.20
  • NNNN N/A
  • Revenue Next Year
  • ALG $5.52
  • NNNN N/A
  • P/E Ratio
  • ALG $19.15
  • NNNN $514.41
  • Revenue Growth
  • ALG N/A
  • NNNN 21.95
  • 52 Week Low
  • ALG $157.07
  • NNNN $5.18
  • 52 Week High
  • ALG $233.29
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • ALG 44.98
  • NNNN 34.18
  • Support Level
  • ALG $178.02
  • NNNN $26.05
  • Resistance Level
  • ALG $186.72
  • NNNN $30.65
  • Average True Range (ATR)
  • ALG 3.88
  • NNNN 2.80
  • MACD
  • ALG 1.37
  • NNNN -0.00
  • Stochastic Oscillator
  • ALG 81.10
  • NNNN 2.84

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: